Feb 2 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS RECEIVES ETHICS COMMITTEE APPROVAL IN TURKEY TO DOSE ADDITIONAL PATIENTS IN THE PHASE II TRIAL FOR LSALT PEPTIDE
Feb 2 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS RECEIVES ETHICS COMMITTEE APPROVAL IN TURKEY TO DOSE ADDITIONAL PATIENTS IN THE PHASE II TRIAL FOR LSALT PEPTIDE